Cantel Medical Board Of Directors Authorizes 20% Increase In Semiannual Dividend

Oct 16, 2015, 09:19 ET from Cantel Medical Corp.

LITTLE FALLS, N.J., Oct. 16, 2015 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.05 to $0.06 per outstanding share of the Company's Common Stock. The dividend is payable on January 29, 2016 to shareholders of record at the close of business on January 15, 2016.

Charles M. Diker, Chairman of the Board, said, "We are pleased to announce the increase in our dividend, which will raise our annual dividend payment from $0.10 to $0.12 per share. The 20% increase in our dividend demonstrates Cantel's strong financial position and our confidence in Cantel's future performance."

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. 

For further information, visit the Cantel website at www.cantelmedical.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.

SOURCE Cantel Medical Corp.



RELATED LINKS

http://www.cantelmedical.com